All manuscripts should be written on A4 white papers, and 2.5 cm-wide margins should be left blank from all sides of the manuscript. The references should be numbered consecutively in the order of their first mention in the text. All text material including references, footnotes, and legends of tables, and figures should be typed double-spacing in font size 11 with left alignment, and without hyphenated line breaks. To set left indent for the paragraph click TAB button once. Fonts of Times New Roman or Arial should be used in the text, for symbols, and other special writing characteristics. Please use editing features of your word processing program to type bold, italic letters, mathematic symbols, and Greek letters, subscripts, and superscripts. Please take care not to confuse between letters O, and I with numerals 0, and 1, respectively. As measurement units only SI (International System of Units) system should be used. Abbreviations and acronyms should be written in parentheses following their explicit open forms or explanations given in their first appearance in the text. Please review the final version of the manuscript very carefully, especially for formatting, and editing errors.
All pages of the manuscript should be consecutively numbered starting from the title page (1. page, title page; 2. page, Turkish abstract; 3. page English abstract etc.) Page numbers should be indicated on the right upper corner of each page.
Final version of the manuscripts should be typed in “doc” or “rtf” format. Manuscripts submitted in “PDF” format will not be accepted.
Writing rules of the Journal are based on the document entitled Uniform Requirements for Manuscripts Submitted to Biomedical Journals - International Committee of Medical Journal Editors (www.icmje.org).
Maximum word length, number of authors, references, and table/figures should be based on the following table.
|Letter to editor
|How to section
|*including title page, abstract, figure legend, and table
|for meta-analyses and systematic reviews all authors
Sections of the Manuscript
All research articles must contain the following sections: (1) Title page, (2) Abstract with key words, (3) Introduction, (4) Methods, (5) Results, (6) Discussion , (7) Acknowledgments, (8) Conflict of interest, (9) Funding resources, (10) References, (11) Figure legends, (12) Tables, (13) Figures. In case of need, presentation of Methods, Results, and Discussion sections under subheadings is preferred. Case reports should be presented following abstract section, under headings of introduction, case presentation, and discussion. In review articles, appropriate headings can be used in accordance with the development of the manuscript. Sections of the manuscript in order of their appearance in the text with relevant explanations are listed below.
Title page should contain the following information. (1) Article title, (2) Explicit names, and academic titles of all participating authors, (3) The department(s), and institution(s) of all authors including their city, and country of residence, (4) The name, explicit mailing address, phone and fax numbers, e-mail address of the corresponding author, (5) Word counts (including title page, abstract, figures legends, and tables).
If the study was presented elsewhere, it should be indicated separately on the title page.
Following title page, abstract should be written on separate page. Abstracts should individually contain at most 250 words, and structured as follows: (1) Objective, (2) Methods, (3) Results, and (4) Conclusion. Under the above headings briefly, subject of the article, method of the study, basic findings, and conclusion arrived by the authors based on these findings should be provided. In the abstracts of the case report, any subtitle should not be used. In abstracts minimal number of abbreviations and/or acronyms should be used. Abstracts should not contain any reference. At most five key words should be written at the bottom of the abstract page.For the selection of keywords, please refer to the “Medical Subject Headings (MeSH)” prepared by US National Library of Medicine (NLM).
Available data relevant to the study subject, and specific purpose of the study should be stated.
The study method, selection of the participants, and the methods used should be described in detail. For the known methods references should be cited. Novel or modified methods used should be described in detail. Doses, concentrations, routes, and duration of administration of the drugs, and chemical agents should be indicated. In the Methods section, under a subtitle, all statistical methods used for summarizing available data, and for testing the proposed hypothesis, and a p value criteria determined for statistically significant difference should be briefly, and concisely recorded. All manuscripts accepted for publication should be statistically evaluated in detail. Standard statistical methods should be used as far as possible. If rarely employed and novel statistical methods were used, then relevant references should be cited. In case of need, more detailed explanations about unusual, complex or new statistical methods can be provided in separate files for the readers as online supplementary data. Commercial name and version number of the statistical software package program should be mentioned. For statistical evaluations recommendations in the statistics section of the document entitled “Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication,” (http://www.ICMJE.org) should be taken into consideration.
Results should be presented in logical sequence, and in detail as much as possible. They should be supported by figures, and tables. Information given in figure(s), and table(s) should not be repeated in the text, unless absolutely required.
Mainly data relevant to the study subject matter should be discussed, and substantiated by references retrieved from domestic and international sources. General information irrelevant to the subject matter should not be dealt with in prolonged discussions.
Names of the individuals who contributed to the study but failed to meet the criteria of authorship should be mentioned in this section. Approvals of all the individuals mentioned in the Acknowledgment section should be obtained.
Conflict of Interest
All potential conflicts of interest should be declared under this heading. All affiliations with pharmaceutical firms, biomedical device manufacturers, and other service or product procurers relevant to the subject matter of the study should be explicitly indicated. If any conflict of interest does not exist, then it should be stated as “none declared.” Declarations related to conflicts of interest should be placed at the bottom of a separate page after Acknowledgments, but before References section. A Conflict of Interest Form will be sent to the authors of accepted papers.
Under this heading titles and /or names of the funds, sponsor foundations or institutions (if any) should be written.
References should be listed consecutively in the order of their first appearance in the text, unpublished results and personal communications should not be cited as references. Unconfirmed references during the preparation stage for publication of the manuscript will be requested from the authors. Titles of the Journals should be abbreviated as indicated in Index Medicus. If not possible, then the full name of the journal should be written. In the References section, only 6 authors should be cited with their full surnames, and then initials of their first names. If more than six authors contributed to the article, then after the name of the 6 first six authors the abbreviation et al. should be added. Notation and listing of the references should comply with the following sample reference citations:
Yüksel H, Güzelsoy D, Yazıcıoğlu N, Şenocak M, Öztürk M, Demiroğlu C. Long-term prognosis after a first myocardial infarction in Turkey: determinants of mortality and reinfarction. Cardiology 1994;84:345-55.
2) Articles in press
Roten L, Derval N, Sacher F, Pascale P, Wilton SB, Scherr D, et al. Ajmaline attenuates electrocardio- gram characteristics of inferolateral early repolarization. Heart Rhythm 2011 Sep 19 [E-pub ahead of print], doi:10.1016/j.hrthm.2011.09.013.
Katz AM. Physiology of the heart. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2000.
4) Chapter in book
Anderson JL, Muhlestein JB. The role of infection. In: Theroux P, editor. Acute coronary syndromes: a companion to Braunwald’s Heart Disease. Philadelphia: W. B. Saunders; 2003. p. 88-107.
5) Web page
Nainggolan L. New salt paper causes controversy. Heartwire. May 3, 2011. Available at: http://www.theheart.org/article/1220043.do. Accessed June 12, 2011.
Reference management softwares (EndNote, Reference Manager, etc.) can be used to facilitate referencing citations. EndNote style for Archives of the Turkish Society of Cardiology can be downloaded from here.
Explanatory notes of each figure should be submitted on a separate paper in order of their appearance in the text immediately after the References section under the heading “figure legends”. All abbreviations, and symbols on the figure should be defined.
Each table should be typed or printed with double-spacing on a separate sheet of paper. Tables should be numbered consecutively in the order of their first citation in the text. Number and title of the table should be placed just above the table. Do not use vertical lines between columns. Horizontal lines should be used only above, and below the headings of the columns, and at the bottom of the table. If required, explanatory notes should be written in footnotes. All abbreviations, and acronyms used in the table should be explained as in footnote in alphabetical order The following symbols should be used in the indicated sequence: *, , , §, ||, ¶, **, , , §§, ||||, ¶¶. Each table should be referred in the text. If you use data from another published or unpublished source, required permissions should be obtained, and all these sources should be acknowledged fully.
Evaluation process of a manuscript does not start unless all figures cited in the text are submitted. Number of figures should be in accordance with the content of the text. Data presented in the text, and tables should not be repeated in figures. All figures should be sent in individual electronic file formats ready for publication with maximal dimensions of 12.5 cm x 18 cm. Illustrations in color should be in CMYK format and at a minimum resolution of 300 DPI. Figure depicted in gray scale should be at least at a resolution of 600 DPI, while minimal resolution required for black-and white illustrations is 1200 DPI. All figures should be typed in TIFF format. Any figure should not disclose or imply the identity of a specific individual. In case of disclosure of personal identity, written permission should be obtained from the individual in question.